isomethyleugenol has been researched along with DIPG Brain Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banda, A; Bayliss, J; Bian, Z; Blüml, S; Chinnaiyan, AM; Chung, C; Cieslik, M; Hawes, D; Judkins, AR; Koschmann, C; Lee, HJ; Lyssiotis, CA; Panwalkar, P; Pratt, D; Qin, T; Shan, M; Shotwell, JB; Sweha, SR; Tamrazi, B; Venneti, S; Wahl, DR; Werner, CK; Yadav, VN; Yang, F | 1 |
| Ehteda, A; Franshaw, L; Giorgi, FM; Gopalakrishnan, A; Gudkov, AV; Gurova, K; Haber, M; Hayden, E; Joshi, S; Kankean, A; Khan, A; Lehmann, R; Liu, J; Mayoh, C; Norris, MD; Pandher, R; Pang, CNI; Rouaen, JRC; Shen, S; Simon, S; Tang, Y; Tolhurst, O; Trebilcock, P; Tsoli, M; Ung, C; Vittorio, O; Ziegler, DS | 1 |
2 other study(ies) available for isomethyleugenol and DIPG Brain Tumors
| Article | Year |
|---|---|
Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.
Topics: Animals; Brain Stem Neoplasms; Cell Line, Tumor; Diffuse Intrinsic Pontine Glioma; Epigenomics; Gene Expression Regulation, Neoplastic; Glycolysis; Histones; Humans; Lysine; Methylation; Mice, Inbred NOD; Mice, Knockout; Mice, Nude; Mice, SCID; Mutation; Transplantation, Heterologous | 2020 |
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.
Topics: Acetylation; Animals; Antineoplastic Agents; Brain Stem Neoplasms; Carbazoles; Cell Cycle Proteins; Cell Line, Tumor; Child; Chromatin; Diffuse Intrinsic Pontine Glioma; DNA-Binding Proteins; Drug Synergism; E2F1 Transcription Factor; Epigenesis, Genetic; Epigenome; High Mobility Group Proteins; Histones; Humans; Methylation; Mice; Neuroglia; Panobinostat; Primary Cell Culture; Retinoblastoma Protein; Signal Transduction; Survival Analysis; Transcription Factors; Transcriptional Elongation Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |